Tonix Pharmaceuticals (TNXP) Stock Chart & Stock Price History $17.39 -0.06 (-0.34%) Closing price 04:00 PM EasternExtended Trading$16.95 -0.44 (-2.50%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tonix Pharmaceuticals Stock Price Performance 5 Day Performance-13.78%1 Month Performance+121.25%3 Month Performance-44.62%6 Month Performance+33.26%Year-To-Date Performance-47.27%1 Year Performance-97.15% Receive TNXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address TNXP Stock Chart for Wednesday, April, 2, 2025 TNXP Chart by TradingViewRemove Ads Tonix Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/01/2025$17.88$17.45-2.40%$19.47$16.511.20 million shs$112.29 million03/31/2025$20.17$17.88-11.35%$23.28$17.851.88 million shs$33.42 million03/28/2025$26.67$20.17-24.37%$25.77$19.422.14 million shs$37.70 million03/27/2025$28.76$26.67-7.27%$28.94$24.351.11 million shs$49.85 million03/26/2025$29.77$28.76-3.39%$31.87$27.501.06 million shs$53.75 million03/25/2025$30.51$29.77-2.43%$31.50$27.041.90 million shs$55.64 million03/24/2025$23.03$30.51+32.48%$37.83$26.557.40 million shs$57.02 million03/21/2025$18.19$23.03+26.61%$23.98$18.363.47 million shs$43.04 million03/20/2025$16.47$18.19+10.44%$18.83$16.641.45 million shs$34.00 million03/19/2025$20.53$16.47-19.78%$19.80$16.081.89 million shs$30.78 million Get the Latest News and Ratings for TNXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/18/2025$16.28$20.53+26.11%$21.70$15.512.63 million shs$38.37 million03/17/2025$15.00$16.28+8.53%$16.50$15.03668,189 shs$30.43 million03/14/2025$13.64$15.00+9.97%$15.67$13.50975,810 shs$28.04 million03/13/2025$13.41$13.64+1.72%$14.09$12.80327,820 shs$25.49 million03/12/2025$13.63$13.41-1.61%$14.06$12.99438,481 shs$25.06 million03/11/2025$13.47$13.63+1.19%$13.67$12.35774,105 shs$25.47 million03/10/2025$13.02$13.47+3.46%$15.90$13.292.27 million shs$25.18 million03/07/2025$14.63$13.02-11.00%$15.30$12.662.10 million shs$24.33 million03/06/2025$10.96$14.63+33.49%$18.63$10.8016.02 million shs$27.34 million03/05/2025$7.80$10.96+40.51%$11.70$8.102.71 million shs$20.48 million03/04/2025$7.38$7.80+5.69%$7.91$6.76391,348 shs$14.58 million03/03/2025$7.86$7.38-6.11%$7.98$7.31230,223 shs$13.79 million Related Companies ADC Therapeutics Stock Price Chart Cybin Stock Price Chart Actuate Therapeutics Stock Price Chart Compugen Stock Price Chart Nkarta Stock Price Chart scPharmaceuticals Stock Price Chart Greenwich LifeSciences Stock Price Chart Tiziana Life Sciences Stock Price Chart Organigram Stock Price Chart Alector Stock Price Chart Receive TNXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TNXP) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNXP Stock Free TNXP Stock Alerts